The new bipyridyl complex of ruthenium(II) with O, O'-diethyl-(S,S)-ethylenediamine-N,N'-di-2-(3-cyclohexyl) 
INTRODUCTION
Bioinorganic chemistry is a field of inorganic chemistry which is constantly evolving, particularly in recent decades, as a growing number of synthesized compounds are widely used for medical and pharmaceutical purposes [1] . Since Rosenberg's discovery of cisplatin, thousands of platinum complexes have been synthesized, in order to find a more suitable anti-tumour drug. Only a small number has entered clinical trials and only two other compounds, carboplatin and oxaliplatin, are currently used worldwide for the treatment of cancer. These three compounds are used in the treatment of approximately 50% of all cancer cases [2] .
The use of these compounds is restricted because of severe dose-limiting side effects; nausea, vomiting, nephrotoxicity, neurotoxicity, myelo-suppression, and ototoxicity are frequently observed [3] . To overcome these problems, the development of novel chemotherapeutics with a different activity profile and mode of action, with lower toxicity and higher selectivity, is essential for the improved treatment of cancer. As a consequence, complexes with other metal ions have become an area of intensive research. The cytotoxic potential of ruthenium complexes was found three decades ago and the utilisation of ruthenium offers several advantages over platinum-based chemotherapy [4, 5] . Ruthenium has the ability to mimic iron in binding to biomolecules, which leads to lower toxic side effects and a different mode of action. Many ruthenium-based drugs are now promising anti-tumour agents, showing lower toxicity in vitro and high activity in in vivo models. Some of them, KP1019 and NAMI-A (Figure 1) , have passed clinical trials and given promising results. The complexes have demonstrated lower general toxicity and activity towards platinumbased drug-resistant tumours [6] . It is known that Ru(II) readily binds to ligands containing sulphur and nitrogen donor atoms. In recent years, the Ru(II) bi-and polypyridyl complexes have been a major focus, as a result of their good photochemical properties and their exhibited anticancer activity [7, 8] .
During the last two decades, large studies have focused on the field of photodynamic therapy (PDT), in which cancer cells are treated with photo-activatable drugs [9] . In this way, side effects can be reduced, which may allow the administration of higher dosages of drugs. The principle of PDT involves the administration of the photoactive agent followed by local illumination of the tumour with light of appropriate wavelength to activate the specific drug. Upon illumination, the PDT agent is excited from its ground state to a singlet excited state, from where it may decay directly back to the ground state, or undergo intersystem crossing (isc) to its long-lived triplet excited state [10, 11] (Figure 2 ). The long-lived triplet excited state of the PDT agent sensitises the production of singlet oxygen ( 1 O 2 ) or produce other reactive oxygen species (ROS), both of which can damage biomolecules [12] . Complexes of rhodium [13, 14] and ruthenium [15] [16] [17] have been extensively studied as agents for PDT. Some of them showed much better activity than cisplatin [18] . A special group of ruthenium complexes are compounds of the formula
, with L-L representing the chelating N,N-ligand. Since Chaberek and Martell first described the chelating ability of ethylendiamine-N,N'-diacetic acid (H 2 edda), it has been of interest for investigation of the mode of coordination of this type of ligand to various metal ions [19] . This class acts toward different compounds including the esters of (S,S)-ethylenediamine-N,N'-di-2-(3-cyclohexyl)propanoic acid. The biological activity of these ligands was investigated towards different cancer cell lines. The results obtained indicate the remarkable anticancer activity of these compounds [20] , which is comparable to cisplatin, or in the case of ethyl ester, even better than cisplatin.
In this paper, we report on the synthesis and characterization of ruthenium(II)-bipyridyl com-
propanoate. This ligand is bidentate and neutral, with an aliphatic cyclohexyl substituent. Due to the bulky ligand and its conformation, it was hypothesized that the synthesized complex has octahedral, cis-geometry ( Figure 3 ). The coordination mode of the ligand was proposed on the basis of UV-Vis, IR, 1 H, 13 C NMR spectroscopy, and ESI-MS spectrometry, compared with the already described analogous complexes and ligands. 
propanoate dihydrochloride was synthesized by following an already described procedure [20] . Thionyl chloride, 2.00 ml (2.70 mmol) and (S,S)-ethylenediamine-N,N'-di-2-(3-cyclohexyl)propanoic acid dihydrochloride, 1.20 g (2.70 mmol) were added to 15 ml ice cooled absolute EtOH. After stirring for 1 h at 0 °C, the suspension was held at reflux for 16 h. The resulting mixture was filtered and left to crystallise. The synthesis was performed according to a slightly modified method of Sullivan [21] . RuCl 3 ·xH 2 O 1.30 g (5 mmol), 2,2 ' -bipyridine 1.56 g (10 mmol) and LiCl 2.1 g (50 mmol) were added in 12.5 ml DMF and refluxed for 8 h with stirring. Afterwards, the solution was cooled to room temperature and 100 ml of a mixture of acetone/water (1:1) was added. A green-black solid was separated by filtration. The solid was added into 100 ml water and stirred for 10 h at r.t., followed by filtration. The product was then washed three times with 12. 2 ] and L·2HCl in the presence of two equivalents of the base, LiOH, in a mixture of ethanol/water solution (Scheme). The desired compounds were precipitated after the addition of ammonium hexafluorophosphate from the reaction mixture. The compound is soluble in acetonitrile and partially soluble in dimethylsulphoxide, but not in water, ethanol or chloroform.
the ligand O,O'-diethyl-(S,S)-ethylenediamine-N,N'-di-2-(3-cyclohexyl)propanoate

Spectroscopic characterization
The IR spectrum of the free ligand (L·2HCl) was compared with the corresponding spectrum of ruthenium(II) complex, cis-[Ru(bpy) 2 L](PF 6 ) 2 to confirm supposed coordination to the metal ion. In the infrared spectrum of the complex, a band around 3420 cm -1 , which is typical for NH vibrations of secondary amines, was observed. In the region 2927-2852 cm -1 , strong and weak bands correspond to CH/CH 2 vibrations of the cyclohexyl group and aliphatic chains. A lack of valence vibrations in the region 2586-2213 cm -1 , which corresponds to valence vibrations of secondary ammonium salt in the free ligand, indicates the coordination via nitrogen donor atoms of the ester ligand. Strong bands corresponding to valence C=O vibrations are in the same position as in the spectrum of the ligand, suggesting that the ligand is not coordinated via oxygen. Other bands are at approximately the same position as in the spectrum of the ligand. The 1 H NMR spectrum of complex showed characteristic bands from the 2,2'-bipyridine ligand in the region 7-10 ppm. Also, NH protons from ligand are, in this region and the sum of the integral absorption corresponds to the number of protons from 2,2'-bipyridine ligand and two NH protons from ester. Protons from ethylene part of ring of complex and protons from -CHNH-group are moved to lower value of shifts, as a consequence of the coordination of the ligand to metal. In the complex, the symmetry of ligand environment is lowered. In the spectrum of complex this is manifested by the non-equivalence of the chemically equivalent protons in free ligands, -(ROOC)-CHNHCH 2 CH 2 NHCH(COOR)-. Signals in the range of 0.87-1.96 ppm correspond to cyclohexyl protons, protons from alkyl group (CH 3 CH 2 OOC-) and protons from -CH 2 Cy and ethylene moiety of ligand. Based on the interpretation of the 13 C NMR spectra of the starting complex, free ligand and synthesized complex, it is clear that only carbons of the ethylene part of the ring in the complex are significantly moved (in the free ligand these are at 41.81 ppm, but in the complex are at 57.12 ppm). Since these carbons are directly bonded for nitrogen atoms, these shifted signals are the result of coordination of the ligand to metal. The synthesized complex has two peaks, at 380 and 471 nm, which correspond to the d-d transition. The appearance of two peaks in the electronic spectrum of d 6 system is typical for octahedral geometry. This transition is in the range of transition bands for the d 6 system and l A 1g ground state for octahedral geometry of ruthenium(II) complexes [22] . Octahedral complexes demonstrate less intensive absorptions then complexes with tetrahedral geometries. Since ∆ t is smaller than ∆ o , the d-d transition in the octahedral complex occurs at a higher energy, and hence at a shorter wavelength.
The assumption that this complex has octahedral geometry is supported by its electronic spectrum (Figure 4) . Efforts to obtain crystals suitable for X-ray analysis included: evaporation of solvent (acetonitrile or DMSO or acetonitrile/DMSO) at room temperature, cooling a saturated solution of the complex in acetonitrile or acetonitrile/DMSO and by solvent diffusion, where we used: water, ethanol, or chloroform as an anti-solvent. None of these methods gave the crystals of desired quality.
CONCLUSION
The complex cis-[Ru(bpy) 2 This complex precipitates as a red powder, which is soluble only in acetonitrile and dimethylsulphoxide. The bidentate ligand is coordinated in the cis position, yielding the complex of octahedral geometry. This was confirmed on the basis of the IR, UV-Vis, 1 H NMR, 13 C NMR spectroscopy and ESI-MS spectrometry. The aims of our further work are the investigation of cytotoxicity and the possibility that this complex is used as a PDT agent.
